|
humans |
48 |
|
female |
39 |
|
interprofessional education |
33 |
|
adult |
32 |
|
middle aged |
29 |
|
partnership model |
28 |
|
social interaction anxiety |
28 |
|
male |
23 |
|
aged |
22 |
|
genetic predisposition to disease |
20 |
|
aged, 80 and over |
19 |
|
antigens, cd - genetics |
18 |
|
adolescent |
17 |
|
brca1 protein - genetics |
16 |
|
cell adhesion molecules - genetics |
16 |
|
polymorphism, single nucleotide - genetics |
16 |
|
tandem repeat sequences |
16 |
|
animals |
15 |
|
case-control studies |
15 |
|
cell adhesion molecules - genetics - metabolism |
15 |
|
gene expression regulation, neoplastic |
15 |
|
homozygote |
15 |
|
l-lactate dehydrogenase - blood |
15 |
|
lectins, c-type - genetics - metabolism |
15 |
|
receptors, cell surface - genetics - metabolism |
15 |
|
asian continental ancestry group - genetics |
14 |
|
breast cancer |
14 |
|
polymorphism, single nucleotide |
14 |
|
promoter regions, genetic - genetics |
13 |
|
child |
12 |
|
cohort studies |
12 |
|
electrophoretic mobility shift assay |
12 |
|
hong kong |
12 |
|
hong kong - epidemiology |
12 |
|
immunohistochemistry |
12 |
|
molecular sequence data |
12 |
|
pregnancy |
12 |
|
severe acute respiratory syndrome - blood - genetics |
12 |
|
apoptosis |
11 |
|
brca1 |
11 |
|
cercopithecus aethiops |
11 |
|
cho cells - virology |
11 |
|
coronavirus |
11 |
|
cricetinae |
11 |
|
cricetulus |
11 |
|
genotype |
11 |
|
intestine, small - physiology |
11 |
|
lung - physiology - virology |
11 |
|
neoplasm staging |
11 |
|
prognosis |
11 |
|
proteasome endopeptidase complex - metabolism |
11 |
|
reverse transcriptase polymerase chain reaction |
11 |
|
sars coronavirus |
11 |
|
sars virus - metabolism - pathogenicity |
11 |
|
severe acute respiratory syndrome - epidemiology - genetics |
11 |
|
species index: animalia |
11 |
|
vero cells - virology |
11 |
|
cell proliferation |
10 |
|
gene frequency |
10 |
|
genetic predisposition to disease - genetics |
10 |
|
polymorphism, genetic |
10 |
|
probability |
10 |
|
transcription, genetic |
10 |
|
young adult |
10 |
|
alleles |
9 |
|
breast neoplasms - genetics - pathology |
9 |
|
diagnosis, differential |
9 |
|
gestational trophoblastic disease |
9 |
|
neoplasm metastasis |
9 |
|
ovarian neoplasms - genetics |
9 |
|
promoter regions, genetic |
9 |
|
brca2 |
8 |
|
breast neoplasms - genetics |
8 |
|
cell adhesion molecules - genetics - physiology |
8 |
|
dna methylation |
8 |
|
dna mutational analysis |
8 |
|
genes, brca1 |
8 |
|
genes, brca2 |
8 |
|
lectins, c-type - genetics |
8 |
|
mutation - genetics |
8 |
|
receptors, cell surface - genetics |
8 |
|
sars virus - isolation and purification - pathogenicity |
8 |
|
severe acute respiratory syndrome - physiopathology - virology |
8 |
|
biopsy, needle |
7 |
|
breast neoplasms - epidemiology - genetics |
7 |
|
cd209 |
7 |
|
cell cycle proteins - analysis |
7 |
|
cell line, tumor |
7 |
|
china |
7 |
|
chinese |
7 |
|
dc-sign |
7 |
|
dna - metabolism |
7 |
|
dna probes - genetics |
7 |
|
dna, mitochondrial - genetics |
7 |
|
dna-binding proteins |
7 |
|
gene frequency - genetics |
7 |
|
hela cells |
7 |
|
heterozygote |
7 |
|
hydatidiform mole - metabolism - pathology |
7 |
|
ki-67 antigen - analysis |
7 |
|
ki67 |
7 |
|
lactate dehydrogenase |
7 |
|
mutation |
7 |
|
nuclear proteins - metabolism |
7 |
|
polymerase chain reaction |
7 |
|
polymorphism, genetic - genetics |
7 |
|
proliferation |
7 |
|
protein binding - genetics |
7 |
|
sars |
7 |
|
snp |
7 |
|
sp1 transcription factor - genetics |
7 |
|
transcription factor ap-2 - genetics |
7 |
|
transfection |
7 |
|
up-regulation |
7 |
|
alanine |
6 |
|
analysis of variance |
6 |
|
androgen receptor |
6 |
|
bq323636.1 |
6 |
|
brca2 protein - genetics |
6 |
|
breast cancer susceptibility gene |
6 |
|
c-mos |
6 |
|
carcinoma - genetics - pathology |
6 |
|
carcinoma, papillary - genetics - metabolism - pathology |
6 |
|
cell transformation, neoplastic - genetics - metabolism |
6 |
|
china - ethnology |
6 |
|
choriocarcinoma |
6 |
|
chromosome in situ hybridization |
6 |
|
communicable diseases - genetics - physiopathology |
6 |
|
confidence intervals |
6 |
|
cpg islands |
6 |
|
cyclin-dependent kinase inhibitor p21 |
6 |
|
cytokines - genetics - metabolism |
6 |
|
gene amplification |
6 |
|
gene mutation |
6 |
|
genes, tumor suppressor |
6 |
|
genital neoplasms, female - metabolism - pathology |
6 |
|
germ cell tumor |
6 |
|
germ-line mutation |
6 |
|
gestational trophoblastic disease - metabolism - pathology |
6 |
|
goiter, nodular - genetics - metabolism - pathology |
6 |
|
gynecological neoplasm |
6 |
|
helix-loop-helix motifs |
6 |
|
hydatidiform mole |
6 |
|
hyperinsulinism |
6 |
|
hypoglycaemia |
6 |
|
id proteins |
6 |
|
immunoblotting |
6 |
|
immunoenzyme techniques |
6 |
|
in situ hybridization - methods |
6 |
|
in situ nick-end labeling |
6 |
|
infant |
6 |
|
inhibitor of differentiation protein 1 |
6 |
|
luciferases - diagnostic use |
6 |
|
management |
6 |
|
microsatellite repeats - genetics |
6 |
|
nuclear proteins - genetics - metabolism |
6 |
|
odds ratio |
6 |
|
open reading frames - genetics |
6 |
|
placenta - chemistry |
6 |
|
placenta - metabolism |
6 |
|
proto-oncogene proteins c-mos - biosynthesis |
6 |
|
rats |
6 |
|
repressor proteins - biosynthesis |
6 |
|
risk factors |
6 |
|
sars virus - genetics - metabolism |
6 |
|
sensitivity and specificity |
6 |
|
severe acute respiratory syndrome - genetics - physiopathology |
6 |
|
signal transduction - genetics |
6 |
|
survival analysis |
6 |
|
tamoxifen resistance |
6 |
|
thyroid gland - cytology - metabolism |
6 |
|
thyroid neoplasms - genetics - metabolism - pathology |
6 |
|
transcription factors - biosynthesis |
6 |
|
transcription factors - genetics - metabolism |
6 |
|
trophoblasts - chemistry - pathology |
6 |
|
tumor cells, cultured |
6 |
|
tumor markers, biological - analysis |
6 |
|
tumor necrosis factor-alpha - genetics - metabolism |
6 |
|
tumor suppressor protein p53 - analysis |
6 |
|
valine |
6 |
|
adenocarcinoma, clear cell - genetics - metabolism - pathology |
5 |
|
antimetabolites, antineoplastic - pharmacology |
5 |
|
antineoplastic-agents-pharmacology |
5 |
|
apoptosis regulatory proteins |
5 |
|
asia |
5 |
|
azacitidine - analogs & derivatives - pharmacology |
5 |
|
base sequence |
5 |
|
blu |
5 |
|
c-dna array |
5 |
|
calcium-calmodulin-dependent protein kinases - genetics |
5 |
|
cancer resistance |
5 |
|
carcinoma, endometrioid - enzymology - genetics |
5 |
|
carcinoma, endometrioid - enzymology - genetics - metabolism - pathology |
5 |
|
carcinoma, endometrioid - enzymology - genetics - pathology |
5 |
|
carcinoma, endometrioid - genetics - metabolism - pathology |
5 |
|
cell cycle proteins |
5 |
|
cervical cancer |
5 |
|
cervix |
5 |
|
child, preschool |
5 |
|
choriocarcinoma-pathology |
5 |
|
chromosome painting |
5 |
|
construct validation |
5 |
|
cystadenocarcinoma, mucinous - genetics - metabolism - pathology |
5 |
|
cystadenocarcinoma, serous - genetics - metabolism - pathology |
5 |
|
cytogenetic analysis - methods |
5 |
|
dapk |
5 |
|
disease progression |
5 |
|
dna damage |
5 |
|
dna hypermethylation |
5 |
|
dna primers |
5 |
|
dna replication |
5 |
|
dna, complementary - analysis |
5 |
|
dna, neoplasm - blood |
5 |
|
dna, neoplasm - chemistry - genetics - metabolism |
5 |
|
dna-binding proteins - analysis |
5 |
|
dnmt1 |
5 |
|
endometrial cancer |
5 |
|
endometrial carcinoma |
5 |
|
endometrial neoplasms - enzymology - genetics |
5 |
|
endometrial neoplasms - enzymology - genetics - metabolism - pathology |
5 |
|
endometrial neoplasms - enzymology - genetics - pathology |
5 |
|
endometrial neoplasms - metabolism - pathology |
5 |
|
gene expression regulation, enzymologic |
5 |
|
gene knockdown techniques |
5 |
|
genes, p16 |
5 |
|
genes, ras |
5 |
|
genotyping |
5 |
|
gestational trophoblastic disease - genetics - pathology |
5 |
|
glutathione s-transferase pi |
5 |
|
glutathione transferase - analysis - genetics - metabolism |
5 |
|
glutathione transferase - genetics |
5 |
|
gtp-binding proteins - genetics - immunology |
5 |
|
hdab2ip |
5 |
|
hydatidiform mole - diagnosis - genetics - pathology |
5 |
|
hydatidiform mole - genetics - pathology |
5 |
|
hydatidiform mole - genetics - pathology - surgery |
5 |
|
immunity, innate |
5 |
|
in situ hybridization |
5 |
|
interferon-alpha - immunology |
5 |
|
interferon-beta - immunology |
5 |
|
interprofessional attitudes |
5 |
|
intracellular signaling peptides and proteins |
5 |
|
isoenzymes - genetics |
5 |
|
ki-67 antigen - biosynthesis |
5 |
|
logistic models |
5 |
|
loss of heterozygosity |
5 |
|
mcl-1 |
5 |
|
mcm7 |
5 |
|
metastatic partial mole |
5 |
|
mgmt |
5 |
|
microdissection |
5 |
|
microsatellite repeats |
5 |
|
minichromosome maintenance protein 7 (mcm7) |
5 |
|
molecular sequence numbers |
5 |
|
multivariate analysis |
5 |
|
neoplasm proteins - genetics - metabolism |
5 |
|
nuclear proteins |
5 |
|
nuclear proteins - analysis |
5 |
|
o(6)-methylguanine-dna methyltransferase - genetics |
5 |
|
ovarian neoplasms - genetics - metabolism - pathology |
5 |
|
ovary - metabolism - pathology |
5 |
|
p16 |
5 |
|
pcna |
5 |
|
placenta - metabolism - pathology |
5 |
|
ploidies |
5 |
|
polymorphism, restriction fragment length |
5 |
|
proliferating cell nuclear antigen - biosynthesis |
5 |
|
promoter cpg island hypermethylation |
5 |
|
proteins - genetics |
5 |
|
proteins - metabolism |
5 |
|
proto-oncogene proteins c-bcl-2 - genetics - metabolism |
5 |
|
ras gtpase-activating proteins - metabolism |
5 |
|
rassf1a |
5 |
|
rassf2a |
5 |
|
repressor proteins - metabolism |
5 |
|
reproducibility of results |
5 |
|
retrospective studies |
5 |
|
rna, messenger - genetics - metabolism |
5 |
|
rna, messenger - metabolism |
5 |
|
rna, neoplasm - analysis |
5 |
|
sars virus - immunology |
5 |
|
severe acute respiratory syndrome - genetics - immunology |
5 |
|
tissue array analysis |
5 |
|
tissue microarray |
5 |
|
tretinoin-pharmacology |
5 |
|
tumor suppressor proteins |
5 |
|
tumor suppressor proteins - metabolism |
5 |
|
uterine cervical neoplasms - blood - enzymology - genetics |
5 |
|
uterine neoplasms - diagnosis - genetics - pathology |
5 |
|
uterine neoplasms - genetics - pathology |
5 |
|
uterine neoplasms - genetics - pathology - surgery |
5 |
|
adenocarcinoma - genetics |
4 |
|
adenocarcinoma - pathology |
4 |
|
age factors |
4 |
|
attitude |
4 |
|
brca2 protein |
4 |
|
breast neoplasms - pathology |
4 |
|
cancer growth |
4 |
|
cancer inhibition |
4 |
|
cancer invasion |
4 |
|
carcinoma, hepatocellular - pathology - surgery |
4 |
|
catheter ablation |
4 |
|
cell transformation, neoplastic - genetics |
4 |
|
centromere |
4 |
|
choriocarcinoma - genetics |
4 |
|
chromosome |
4 |
|
chromosome aberrations |
4 |
|
chromosomes, human, pair 11 |
4 |
|
chromosomes, human, pair 12 |
4 |
|
chromosomes, human, pair 17 |
4 |
|
clinical competence - standards |
4 |
|
clinical competence/*standards |
4 |
|
collagen - metabolism |
4 |
|
comparative genomic hybridization |
4 |
|
controlled study |
4 |
|
cross-sectional studies |
4 |
|
cross-sectional study |
4 |
|
curriculum - standards |
4 |
|
curriculum/ *standards |
4 |
|
cytogenetic study |
4 |
|
cytogenetics |
4 |
|
dna, neoplasm - genetics |
4 |
|
dna, neoplasm - metabolism |
4 |
|
dna,-viral-isolation-and-purification |
4 |
|
drug resistance, neoplasm - genetics |
4 |
|
education, medical, undergraduate - standards |
4 |
|
education, medical, undergraduate/*standards |
4 |
|
endometrial neoplasms - genetics |
4 |
|
endometrial neoplasms - genetics - pathology - ultrastructure |
4 |
|
endometrial stromal sarcoma |
4 |
|
estrogen receptor alpha - biosynthesis - genetics |
4 |
|
extracellular matrix |
4 |
|
faculty, medical |
4 |
|
follow-up studies |
4 |
|
founder effect |
4 |
|
gene expression regulation, neoplastic - genetics |
4 |
|
genetics, population |
4 |
|
genital neoplasms, female - genetics |
4 |
|
genomic instability - genetics |
4 |
|
germ-line mutation - genetics |
4 |
|
gestational age |
4 |
|
gestational trophoblastic disease - genetics |
4 |
|
gynecological cancer |
4 |
|
hepatitis c - complications |
4 |
|
hepatitis c virus |
4 |
|
hepatocellular carcinoma |
4 |
|
herpesvirus-4,-human-isolation-and-purification |
4 |
|
hydatidiform mole - genetics |
4 |
|
hypoxia-inducible factor 1 - genetics - physiology |
4 |
|
interphase |
4 |
|
karyotyping |
4 |
|
laparoscopy |
4 |
|
liver neoplasms - pathology - surgery |
4 |
|
lung metastasis |
4 |
|
mdm2 |
4 |
|
microwave coagulation |
4 |
|
microwaves - therapeutic use |
4 |
|
mitochondrial dna |
4 |
|
mitochondrial microsatellite instability |
4 |
|
neoplasm invasiveness |
4 |
|
neoplasm proteins - genetics |
4 |
|
neoplasm recurrence, local |
4 |
|
nuclear receptor co-repressor 2 - genetics |
4 |
|
ovarian cancer |
4 |
|
ovarian neoplasms - genetics - pathology |
4 |
|
p53 |
4 |
|
placental site trophoblastic tumor |
4 |
|
pregnancy complications, neoplastic - pathology |
4 |
|
pregnancy trimester, third - genetics |
4 |
|
problem-based learning - methods |
4 |
|
questionnaires |
4 |
|
radio waves |
4 |
|
radiofrequency ablation |
4 |
|
receptors, fsh - genetics |
4 |
|
recurrence of hcc |
4 |
|
rna, messenger - biosynthesis - genetics |
4 |
|
sarcoma, endometrial stromal - genetics - pathology - ultrastructure |
4 |
|
somatic mutations |
4 |
|
spain - epidemiology |
4 |
|
teachers |
4 |
|
transcription factors - genetics |
4 |
|
trophoblastic neoplasms - metabolism - pathology |
4 |
|
trophoblastic tumor, placental site - genetics - metabolism - pathology |
4 |
|
tumor markers, biological - genetics - metabolism |
4 |
|
tumor markers, biological - metabolism |
4 |
|
uterine cervical neoplasms - genetics |
4 |
|
uterine neoplasms - genetics - metabolism - pathology |
4 |
|
uterine neoplasms - metabolism - pathology |
4 |
|
vulvar-neoplasms-microbiology |
4 |
|
x chromosome |
4 |
|
abdominal neoplasms - chemistry - pathology |
3 |
|
abortion, spontaneous - metabolism |
3 |
|
adenocarcinoma |
3 |
|
adenoma - blood - complications - pathology |
3 |
|
adrenocorticotropic hormone - blood |
3 |
|
age distribution |
3 |
|
ais |
3 |
|
allele |
3 |
|
alternative splicing |
3 |
|
amino acid sequence |
3 |
|
anastrozole |
3 |
|
antigens, neoplasm |
3 |
|
ar antagonist |
3 |
|
aromatase inhibitor resistance |
3 |
|
asian |
3 |
|
asian screening population |
3 |
|
aspiration biopsy |
3 |
|
association study |
3 |
|
atypical squamous cells of undetermined significance |
3 |
|
biopsy |
3 |
|
breast neoplasms |
3 |
|
breast neoplasms - epidemiology - genetics - pathology |
3 |
|
breast neoplasms - ethnology - genetics |
3 |
|
breast neoplasms - metabolism |
3 |
|
cancer risk |
3 |
|
carcinoma in situ - pathology |
3 |
|
carcinoma, ductal - epidemiology - genetics - pathology |
3 |
|
carcinoma, endometrioid - chemistry - pathology |
3 |
|
carcinoma, hepatocellular - blood - complications - pathology |
3 |
|
carcinoma, lobular - epidemiology - genetics - pathology |
3 |
|
caspase |
3 |
|
caspases - metabolism |
3 |
|
cathepsin d |
3 |
|
cathepsin d - chemistry |
3 |
|
cct241533 |
3 |
|
cell adhesion molecules - chemistry - genetics - physiology |
3 |
|
cell cycle proteins - biosynthesis - genetics |
3 |
|
cell division |
3 |
|
cervical intraepithelial neoplasia - diagnosis |
3 |
|
china - epidemiology |
3 |
|
chinese breast cancer |
3 |
|
chk2 |
3 |
|
chk2 inhibitor |
3 |
|
choriocarcinoma - complications - surgery |
3 |
|
choriocarcinoma - metabolism |
3 |
|
chorionic gonadotropin - blood |
3 |
|
chromosomes, human, pair 11 - genetics |
3 |
|
chromosomes, human, pair 16 |
3 |
|
chromosomes, human, pair 16 - genetics |
3 |
|
clinical |
3 |
|
combined modality therapy |
3 |
|
curriculum |
3 |
|
cxcr1 |
3 |
|
cyclins - metabolism |
3 |
|
cystadenocarcinoma, serous - chemistry - pathology |
3 |
|
cystadenoma, mucinous - chemistry - pathology |
3 |
|
cystadenoma, serous - chemistry - pathology |
3 |
|
cytology |
3 |
|
dedifferentiation |
3 |
|
dendritic cells - immunology |
3 |
|
desmin - analysis |
3 |
|
desmoplastic reaction |
3 |
|
disease susceptibility - immunology |
3 |
|
dna repair - genetics |
3 |
|
dna topoisomerases, type ii - analysis |
3 |
|
drug resistance, neoplasm |
3 |
|
education, medical - organization & administration |
3 |
|
education, premedical - organization & administration |
3 |
|
endometrial neoplasms - genetics - pathology |
3 |
|
ependymoma |
3 |
|
epithelioid cells - drug effects - pathology |
3 |
|
european |
3 |
|
forkhead transcription factors - metabolism |
3 |
|
foxm1 |
3 |
|
foxo3a |
3 |
|
gastric adenocarcinoma |
3 |
|
gender |
3 |
|
genes, erbb-2 |
3 |
|
genital neoplasms, female - epidemiology - pathology |
3 |
|
glioma - pathology |
3 |
|
heterozygosity |
3 |
|
hirsutism - blood - etiology |
3 |
|
homozygosity |
3 |
|
hormone receptors |
3 |
|
human |
3 |
|
hydatidiform mole - blood - complications - drug therapy - surgery |
3 |
|
hydrocortisone - blood |
3 |
|
in situ hybridization, fluorescence |
3 |
|
incidence |
3 |
|
infection |
3 |
|
infection - genetics |
3 |
|
infection sensitivity |
3 |
|
interleukin-8 |
3 |
|
isoleucine - genetics |
3 |
|
keratins - metabolism |
3 |
|
keywords |
3 |
|
keywords: liver cell adenoma, bile pigment, hirsutism, child |
3 |
|
lectins |
3 |
|
lectins, c-type - chemistry - genetics - physiology |
3 |
|
letter |
3 |
|
ligands |
3 |
|
liver neoplasms - blood - complications - pathology |
3 |
|
m30 |
3 |
|
malignant melanoma |
3 |
|
mass screening |
3 |
|
medical sciences |
3 |
|
melanoma - epidemiology - pathology |
3 |
|
membrane glycoproteins - analysis |
3 |
|
mi/ai ratio |
3 |
|
mitotic index |
3 |
|
models, biological |
3 |
|
molecular epidemiology |
3 |
|
molecular genetics |
3 |
|
mucin-1 |
3 |
|
myxopapillary |
3 |
|
neoplasm proteins - metabolism |
3 |
|
neoplasms, nerve tissue - chemistry - pathology |
3 |
|
novel target |
3 |
|
obstetrics and gynecology |
3 |
|
oestrogen receptor |
3 |
|
ovarian neoplasms - chemistry - pathology |
3 |
|
ovarian neoplasms - ethnology - genetics |
3 |
|
p21(waf1/cip1) |
3 |
|
paraneoplastic syndromes - diagnosis - etiology |
3 |
|
pathology |
3 |
|
phosphopyruvate hydratase - analysis |
3 |
|
population genetics |
3 |
|
priority journal |
3 |
|
program evaluation |
3 |
|
protein isoforms - chemistry - genetics - metabolism |
3 |
|
receptor, epidermal growth factor |
3 |
|
receptors, cell surface - chemistry - genetics - physiology |
3 |
|
receptors, estrogen - chemistry |
3 |
|
receptors, progesterone - chemistry |
3 |
|
recurrence |
3 |
|
risk |
3 |
|
risk assessment |
3 |
|
sacrococcygeal region |
3 |
|
sarcoma, endometrial stromal - genetics - pathology |
3 |
|
severe acute respiratory syndrome |
3 |
|
sex factors |
3 |
|
small round‐cell tumour |
3 |
|
soft tissue neoplasms - pathology |
3 |
|
srpk1 |
3 |
|
srsf5 |
3 |
|
stomach neoplasms - pathology |
3 |
|
structural biology |
3 |
|
students, premedical - psychology |
3 |
|
tandem repeat |
3 |
|
tma |
3 |
|
transcription |
3 |
|
trophoblastic neoplasms - complications - drug therapy - surgery |
3 |
|
trophoblastic tumor, placental site - metabolism - pathology |
3 |
|
uterine cervical neoplasms - diagnosis |
3 |
|
uterine cervical neoplasms - diagnosis - genetics |
3 |
|
uterine cervical neoplasms - epidemiology - pathology - surgery |
3 |
|
uterine cervical neoplasms - pathology |
3 |
|
uterine neoplasms - blood - complications - drug therapy - surgery |
3 |
|
vagina |
3 |
|
vaginal neoplasms - epidemiology - pathology - radiotherapy - surgery |
3 |
|
vaginal smears |
3 |
|
valine - genetics |
3 |
|
variant of unknown significance |
3 |
|
vascular endothelial growth factor a - metabolism |
3 |
|
vegf |
3 |
|
vimentin - analysis |
3 |
|
vulva |
3 |
|
vulvar neoplasms - epidemiology - pathology - radiotherapy - surgery |
3 |
|
vus |
3 |
|
young. |
3 |
|
adenocarcinoma - diagnosis - pathology |
2 |
|
adenocarcinoma - secondary |
2 |
|
adenovirus e1a proteins - metabolism - physiology |
2 |
|
adrenal cortex - pathology |
2 |
|
ak 47 cell line |
2 |
|
antibodies, monoclonal |
2 |
|
ascitic fluid - chemistry - pathology |
2 |
|
biomarker |
2 |
|
brain - pathology |
2 |
|
brca |
2 |
|
breast - cancer - genetic aspects. |
2 |
|
breast - pathology |
2 |
|
breast cancer cell line |
2 |
|
breast neoplasms - diagnosis - epidemiology - genetics |
2 |
|
breast neoplasms - diagnosis - genetics - metabolism - pathology |
2 |
|
breast neoplasms - etiology - genetics - pathology |
2 |
|
breast neoplasms - genetics - metabolism - pathology |
2 |
|
c-myc |
2 |
|
ca-125 antigen - blood |
2 |
|
ca-19-9 antigen - blood |
2 |
|
ca125 |
2 |
|
ca15.3 |
2 |
|
ca19.9 |
2 |
|
cancer staging |
2 |
|
carcinoid tumor |
2 |
|
carcinoid tumor - genetics |
2 |
|
carcinoma - metabolism - secondary |
2 |
|
carcinoma, ductal - diagnosis - genetics - metabolism - pathology |
2 |
|
carcinoma, endometrioid - pathology |
2 |
|
carcinoma, papillary - genetics |
2 |
|
carcinoma, squamous cell - diagnosis - pathology |
2 |
|
carcinoma, squamous cell - genetics |
2 |
|
cell line |
2 |
|
cell nucleus - drug effects - metabolism |
2 |
|
cell nucleus - pathology |
2 |
|
cervical intraepithelial neoplasia - diagnosis - pathology |
2 |
|
cervix uteri - pathology |
2 |
|
cesarean section |
2 |
|
chemoresistance |
2 |
|
chromosomes, human, pair 10 - genetics |
2 |
|
cish |
2 |
|
collision tumor |
2 |
|
comparison |
2 |
|
conventional smear |
2 |
|
cytogenetic analysis |
2 |
|
death, sudden - etiology - pathology |
2 |
|
dermoid cyst |
2 |
|
desmin - analysis - immunology |
2 |
|
digits |
2 |
|
eif4e |
2 |
|
endometrial neoplasms - diagnosis - surgery - therapy |
2 |
|
endometrioid carcinoma |
2 |
|
epirubicin |
2 |
|
epithelial-mesenchymal transition |
2 |
|
epithelial-mesenchymal transition - physiology |
2 |
|
fallopian tube |
2 |
|
fibroma - pathology - surgery - ultrastructure |
2 |
|
foot diseases - pathology - surgery |
2 |
|
forkhead transcription factors - genetics - metabolism |
2 |
|
genital neoplasms, female - diagnosis - pathology |
2 |
|
genome-wide association study |
2 |
|
germ cell tumors |
2 |
|
ham56 |
2 |
|
hla antigens - genetics |
2 |
|
hnpcc |
2 |
|
hysterectomy |
2 |
|
hysteroscopy |
2 |
|
immunogenetic phenomena |
2 |
|
interleukin-6 |
2 |
|
interleukin-6 receptor |
2 |
|
intramyocardial haemorrhage |
2 |
|
kidney - pathology |
2 |
|
leiomyosarcoma - pathology |
2 |
|
liver neoplasm |
2 |
|
lymphatic metastasis |
2 |
|
macrophages, alveolar - immunology |
2 |
|
malignant transformation |
2 |
|
maternal death |
2 |
|
menopause - genetics |
2 |
|
metastatic adenocarcinoma |
2 |
|
microscopy, electron |
2 |
|
microtomy |
2 |
|
mixed tumor, mullerian - diagnosis - pathology |
2 |
|
mixed tumor, mullerian - pathology |
2 |
|
mucin-1 - blood |
2 |
|
myocardium - pathology |
2 |
|
nasopharyngeal carcinoma |
2 |
|
nasopharyngeal neoplasms - metabolism - pathology |
2 |
|
nbs1 |
2 |
|
ncor2 |
2 |
|
neoplasm proteins - metabolism - physiology |
2 |
|
neoplasm recurrence, local - pathology - surgery - ultrastructure |
2 |
|
neoplasms, unknown primary - diagnosis |
2 |
|
novel treatment |
2 |
|
nrf2 |
2 |
|
osseous |
2 |
|
osteoma - chemistry - pathology - surgery |
2 |
|
ovarian |
2 |
|
ovarian neoplasms - pathology |
2 |
|
ovaries - cancer - genetic aspects. |
2 |
|
ovary |
2 |
|
p53 expression |
2 |
|
pea3 |
2 |
|
peritoneal fluid |
2 |
|
peutz-jeghers |
2 |
|
pregnancy complications, hematologic - pathology |
2 |
|
primary hepatic neuroendocrine tumor |
2 |
|
protein-serine-threonine kinases - genetics |
2 |
|
proto-oncogene proteins - metabolism - physiology |
2 |
|
proto-oncogene proteins c-akt - metabolism |
2 |
|
pseudotumor |
2 |
|
puerperal disorders - mortality - pathology |
2 |
|
purpura, thrombotic thrombocytopenic - mortality - pathology |
2 |
|
pyogenic granuloma |
2 |
|
recurrent nodal metastasis |
2 |
|
resistance |
2 |
|
reverse transcriptase polymerase chain reaction - methods |
2 |
|
ribosome biogenesis |
2 |
| dna damage |
2 |
|
sarcoma |
2 |
|
sarcoma - diagnosis - pathology |
2 |
|
sarcoma, endometrial stromal - diagnosis - pathology |
2 |
|
sarcoma, endometrial stromal - pathology |
2 |
|
sars virus - pathogenicity |
2 |
|
senescence |
2 |
|
severe acute respiratory syndrome - epidemiology - genetics - immunology |
2 |
|
snail |
2 |
|
soft tissue neoplasms - pathology - surgery - ultrastructure |
2 |
|
soft tissues |
2 |
|
specimen handling |
2 |
|
splice variant bq |
2 |
|
stromal sarcoma |
2 |
|
targeted therapy |
2 |
|
teratoma |
2 |
|
teratoma - genetics |
2 |
|
thinprep papanicolaou test |
2 |
|
thrombotic thrombocytopaenic purpura |
2 |
|
thyroid neoplasms - genetics |
2 |
|
tocilizumab |
2 |
|
toes |
2 |
|
transcription factors - genetics - physiology |
2 |
|
tumor markers, biological |
2 |
|
tumor suppressor protein p53 - biosynthesis |
2 |
|
usp7 |
2 |
|
uterine cancer |
2 |
|
uterine cervical neoplasms - diagnosis - pathology |
2 |
|
uterine neoplasms - chemistry - diagnosis - pathology |
2 |
|
uterine neoplasms - pathology |
2 |
|
uterus |
2 |
|
vaginal smears - methods |
2 |
|
临床生物学行为 |
2 |
|
妊娠滋养 |
2 |
|
异常增生 |
2 |
|
异质 |
2 |
|
形态学 |
2 |
|
性疾病 |
2 |
|
概念 |
2 |
|
滋养细胞疾病 |
2 |
|
滋养细胞肿瘤 |
2 |
|
特征 |
2 |
|
病变 |
2 |
|
adhesion molecules |
1 |
|
algorithms |
1 |
|
aneurysm, dissecting - classification - diagnosis - epidemiology - etiology |
1 |
|
aorta - pathology |
1 |
|
aortic aneurysm - classification - diagnosis - epidemiology - etiology |
1 |
|
aortic dissection |
1 |
|
biopsy, fine-needle |
1 |
|
blood chemical analysis |
1 |
|
blood transfusion - adverse effects |
1 |
|
bloodless |
1 |
|
breast diseases - diagnosis - etiology |
1 |
|
breast neoplasms - diagnosis - etiology |
1 |
|
breast neoplasms - epidemiology - ethnology - genetics |
1 |
|
breast neoplasms - pathology - radiography - ultrasonography |
1 |
|
calcinosis - diagnosis - etiology |
1 |
|
carcinoma - epidemiology - ethnology - genetics |
1 |
|
causality |
1 |
|
cell differentiation |
1 |
|
cell transformation, neoplastic - pathology |
1 |
|
chemokine (c-x-c motif) ligand 12 (cxcl12) |
1 |
|
chromosomes, human, pair 6 - genetics |
1 |
|
cxc chemokine receptor types 4 (cxcr4) |
1 |
|
cystic medionecrosis |
1 |
|
cytoskeletal proteins |
1 |
|
death, sudden - etiology |
1 |
|
decision theory |
1 |
|
diabetes mellitus |
1 |
|
diagnostic tests |
1 |
|
echocardiography |
1 |
|
electrocardiography |
1 |
|
erythema - pathology |
1 |
|
european continental ancestry group - genetics |
1 |
|
expected utility |
1 |
|
fibrosis |
1 |
|
glucagonoma - pathology |
1 |
|
her2-neu |
1 |
|
her2-positive breast cancer |
1 |
|
jaundice |
1 |
|
jaundice - diagnosis - radiography |
1 |
|
luminal breast cancer |
1 |
|
lymphoma, t-cell, cutaneous - pathology - radiography - ultrasonography |
1 |
|
mammary tumor |
1 |
|
mammography |
1 |
|
myoepithelial marker genes |
1 |
|
necrosis |
1 |
|
pancreatic neoplasms - pathology |
1 |
|
panniculitis - pathology - radiography - ultrasonography |
1 |
|
pdz-binding domain |
1 |
|
predictive value of tests |
1 |
|
premenopause |
1 |
|
prospective studies |
1 |
|
pten |
1 |
|
purpura, thrombotic thrombocytopenic - etiology |
1 |
|
regression analysis |
1 |
|
remission, spontaneous |
1 |
|
retroperitoneal neoplasms - diagnosis - pathology |
1 |
|
rhabdomyoma - diagnosis - pathology |
1 |
|
skin neoplasms - pathology - radiography - ultrasonography |
1 |
|
sudden death |
1 |
|
syndrome |
1 |
|
teratoma - diagnosis - pathology |
1 |
|
triple negative breast cancer |
1 |
|
tunica media - pathology |
1 |
|
ultrasonography, mammary |
1 |
|
vimentin |
1 |
|
visceral organ specificmetastases |
1 |
|
wilms tumor - diagnosis - pathology |
1 |
